SCHEMBL17906205

SCHEMBL17906205

Cc1c(C)n(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.59
▸ ATM Q13315 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ GPR3 P46089 1/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.41
▸ RORC P51449 1/20 0.41
▸ PLA2G2A P14555 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ POLB P06746 1/20 0.39
▸ USP14 P54578 2/20 0.39
▸ HTT P42858 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ GFER P55789 1/20 0.37
▸ PTPN1 P18031 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18969703 0.90 KDM4E (0.47) KDM4EATML3MBTL1HDAC6RORC
SCHEMBL11379057 0.90 KDM4E (0.61) KDM4EATML3MBTL1RORCPLA2G2A
SCHEMBL17906201 0.87 KDM4E (0.44) KDM4EATML3MBTL1HDAC6RORC
SCHEMBL2758580 0.87 KDM4E (0.44) KDM4EATML3MBTL1HDAC6RORC
SCHEMBL11986606 0.86 KDM4E (0.48) KDM4EATML3MBTL1GPR3HDAC6
SCHEMBL12757623 0.85 KDM4E (0.52) KDM4EATML3MBTL1GPR3HDAC6
SCHEMBL17367768 0.84 KDM4E (0.60) KDM4EATML3MBTL1RORCPLA2G2A
SCHEMBL22454015 0.84 KDM4E (0.41) KDM4EATML3MBTL1HDAC6RORC
SCHEMBL7140707 0.84 MAPT (0.54) KDM4EATML3MBTL1ALDH1A1POLB
SCHEMBL10021229 0.84 KDM4E (0.50) KDM4EATML3MBTL1GPR3HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-9966537-B2 Compositions with 2,3-disubstituted indoles as charge transport materials, and display devices fabricated therefrom DOW GLOBAL TECHNOLOGIES LLC (US) 2018-05-08 — — US disclosed
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom DOW GLOBAL TECHNOLOGIES LLC 2017-12-28 — — US disclosed
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom DOW GLOBAL TECHNOLOGIES LLC 2017-12-28 — — US disclosed
WO-2016107459-A1 COMPOSITIONS WITH 2, 3-DISUBSTITUTED INDOLES AS CHARGE TRANSPORT MATERIALS, AND DISPLAY DEVICES FABRICATED THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2016-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170373253-A1 Compositions with 2,3-Disubstituted Indoles as Charge Transport Materials, and Display Devices Fabricated Therefrom IDO2, HTR3D, IDO1 KDM4E 3319/4885ATM 4371/4885L3MBTL1 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback